Since we observed differences in apoptosis and cell cycle arrest following pevonedistat treatment in neuroblastoma cells, we hypothesized that the effects of pevonedistat would differ for DNA replication proteins degraded by the CLN-ubiquitin system. This evidence concerns the gene PROS1 and neuroblastoma.